Solventum (SOLV) Financials

Solventum’s latest quarter shows a business that is still generating solid revenue, but profitability and cash flow remain under pressure. In Q1 2026, revenue was essentially flat year over year at $2.007 billion versus $1.998 billion in Q4 2025 and $2.070 billion in Q1 2025, but operating income fell sharply to $81 million from $125 million in the prior quarter and $152 million a year ago. The company also posted negative operating cash flow in the quarter, which is a caution sign for investors.

• Q1 2026 revenue held relatively steady at $2.007 billion, showing that demand remains stable despite a challenging backdrop.
• Gross profit improved to $1.097 billion in Q1 2026, up from $1.027 billion in Q4 2025, indicating better production or pricing mix.
• The company remained profitable on a net basis in Q1 2026, with $12 million of net income attributable to common shareholders.
• Cash on the balance sheet increased to $561 million at the end of Q1 2026 from $492 million at the end of Q2 2025, giving Solventum some liquidity support.
• Short-term debt fell to $505 million in Q1 2026 from $0 in Q3 2025 and $200 million in Q4 2024, suggesting some balance-sheet cleanup versus earlier periods.
• Revenue has stayed in a fairly tight range over the last year, generally around $2.0 billion to $2.1 billion per quarter, which suggests the top line is stable but not accelerating.
• R&D spending remained consistent at about $189 million in Q1 2026, showing continued investment in the business.
• The company still carries a large goodwill and intangible asset base, which is common after separation and acquisitions, but it leaves the balance sheet exposed to potential impairment risk.
• Operating cash flow was negative $189 million in Q1 2026, down from positive $95 million in Q4 2025 and positive $169 million in Q2 2025.
• Free cash generation weakened sharply because operating cash flow did not cover capital spending, making the quarter cash-consuming overall.
• Operating margin compressed to about 4.0% in Q1 2026, down from 6.3% in Q4 2025 and 7.3% in Q1 2025, showing pressure on profitability.
• Interest and other non-operating items were a drag again, with total other expense of $66 million in Q1 2026, which reduced pretax income to just $16 million.
• Long-term debt rose to $4.575 billion in Q1 2026 from $0 in Q3 2025 and was still a major claim on the business, limiting financial flexibility.
• Total equity remains modest relative to assets and liabilities, and the balance sheet is still heavily leveraged.

Longer-term trend: Solventum’s 2025 results showed that the company can produce strong quarters, especially in Q3 2025 when operating income spiked to $1.69 billion due to a large restructuring item and EPS jumped sharply. But that kind of volatility also highlights that reported earnings can swing materially from one quarter to the next. Underneath that noise, the core picture is mixed: revenue has been stable, margins have been uneven, and cash flow has not been consistently strong.

Bottom line: Solventum looks like a company with a durable revenue base, but investors should watch cash flow, leverage, and margin consistency closely. The latest quarter was not bad on the top line, but the weak operating cash flow and thin operating profit suggest the stock still depends on execution improvement before the fundamentals look clearly stronger.